-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Revance Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2013 to Q2 2024.
- Revance Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 104M shares, a 24.1% increase year-over-year.
- Revance Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 84.6M shares, a 16.3% increase from 2022.
- Revance Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 72.7M shares, a 7.71% increase from 2021.
- Revance Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 67.5M shares, a 16.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)